Blindness: Latest News, Top Stories & Analysis

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced the dosing of the first patient in its Phase 1 clinical trial for OCU200, a potential treatment for diabetic macular edema …

Regional

Combating the ‘Silent Thief of Sight’: MOA Takes Aim at Glaucoma

January 14, 2024January 13, 2024 - by Timothy Alexander

HORSHAM, PA — In observance of January as Glaucoma Awareness Month, Medical Optometry America (MOA) is underscoring its dedication to battling glaucoma, a foremost contributor to irreversible vision loss and …